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Summary
Background.— The choice of the optimal left ventricular (LV) pacing site remains an issue in
patients requiring cardiac resynchronization therapy (CRT).
Aim.— This prospective study compared the outcome of patients paced at the most delayed LV
region with that of patients paced at any other LV site.
Methods.— Forty-four patients with severe heart failure underwent three-dimensional (3D)
echocardiography before implantation and 3 days after implantation of a CRT device, to deter-
mine the most delayed LV region during spontaneous rhythm and during right ventricular pacing.
The patients were divided subsequently into four groups: group 1 (n = 19), LV lead placed at the
most delayed echocardiographic site in spontaneous rhythm; group 2 (n = 25), LV lead placed
at any other site; group 3 (n = 21), LV lead placed at the most delayed echocardiographic site
during right ventricular pacing; group 4 (n = 23), LV lead placed at any other site.
Results.— No signiﬁcant differences were observed between the four groups before implanta-
tion. After 6months of CRT, no signiﬁcant differences were observed between groups 1 and 2
or between groups 3 and 4 in terms of change in New York Heart Association functional class,
Minnesota living with heart failure questionnaire, 6-minute walk test, peak exercise oxygen
consumption, 3D ventricular dyssynchrony and 3D LV ejection fraction.
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Conclusion.— L’implantation de la sonde ventriculaire gauche dans la paroi la plus retardée
n’a pas permis d’apporter un bénéﬁce supplémentaire en termes de symptômes et de fonction
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bbreviations
D three-dimensional
RT cardiac resynchronization therapy
V left ventricular
VEDV left ventricular end-diastolic volume
VEF left ventricular ejection fraction
VESV left ventricular end-systolic volume
ntroduction
RT has an established role in the management of patients
ith advanced heart failure and prolonged QRS duration
1—3]. However, one third of patients do not respond to CRT,
espite the application of established electrocardiographic
election criteria [4]. To improve outcome and reduce the
roportion of non-responders, three different and com-
lementary approaches have been proposed: optimization
f patient selection; optimization of LV lead placement
nd optimization of the programming of the CRT device
5—10]. To date, identiﬁcation of the optimal LV lead posi-
ion has attracted little attention. Previous studies have
uggested that implantation of the LV lead in the area of
he most delayed pre-implantation echocardiographically-
etermined electromechanical activation may be associated
ith an improvement in the response to CRT and a decrease
n the proportion of non-responders [11—13]. Similarly,
lacement of the LV electrode in the area with maximal
elay during right ventricular pacing may optimize the elec-
romechanical activation. The aim of the present study was
S
A
as droits réservés.
o evaluate, by use of 3D echocardiography, the putative
avourable impact on the efﬁcacy of CRT, in terms of ven-
ricular dyssynchrony and midterm clinical status, of an
chocardiographically-optimized LV lead position targeting
he exact region of maximal mechanical delay during spon-
aneous rhythm and during right ventricular pacing.
ethods
tudy population
orty-four successive patients with refractory heart failure
ue to severe systolic dysfunction, prolonged QRS duration,
n sinus rhythm and scheduled for implantation of a CRT
evice were enrolled prospectively. Refractory heart failure
as deﬁned by the persistence of New York Heart Associa-
ion functional class III or IV despite optimal pharmacological
herapy. Severe systolic dysfunction was deﬁned by a LVEF
ess than 35%, while prolonged QRS duration was deﬁned by a
RS width greater than 120ms. Patients were excluded from
he study if they had a history of sustained atrial arrhyth-
ias or complete atrioventricular block or a poor ultrasonic
indow that did not allow exploitable 3D acquisitions. All
atients provided written, informed consent to the study,
hich was approved by the institutional clinical research
nd ethics committee.A. Deplagne et al.
Conclusion.— Implantation of the LV lead in the most delayed region of the left ventricle deter-
mined by 3D echocardiography did not result in additional improvement in symptoms or LV
function.
© 2009 Elsevier Masson SAS. All rights reserved.
Résumé
Introduction.— Chez les patients bénéﬁciant d’une resynchronisation biventriculaire, le choix
du site optimal de stimulation ventriculaire gauche reste controversé. Cette étude prospective
compare le devenir de patients stimulés au niveau de la région ventriculaire gauche (VG) la
plus retardée et le devenir de patients stimulés dans une autre région.
Méthode.— Quarante-quatre patients insufﬁsants cardiaques bénéﬁcièrent d’une échocardio-
graphie tridimensionnelle (3D) avant l’implantation et trois jours après pour déterminer la paroi
la plus retardée en rythme spontané (RS) et lors d’une stimulation ventriculaire droite (VD).
Les patients étaient divisés en quatre groupes : groupe 1 (n = 19) : sonde VG placée au niveau de
la paroi la plus retardée en RS ; groupe 2 (n = 25) : sonde VG placée sur une autre paroi ; groupe
3 (n = 21) : sonde VG placée au niveau de la paroi la plus retardée lors d’une stimulation VD ;
groupe 4 (n = 23) : sonde VG placée sur une autre paroi.
Résultats.— Nous n’avons pas retrouvé de différence signiﬁcative entre les quatre groupes
avant l’implantation. Après six mois de stimulation, nous n’avons pas retrouvé de différence
signiﬁcative entre les patients des groupes 1 et 2 et des patients des groupes 3 et 4 en termes
de modiﬁcation de classe New York Heart Association, de questionnaire de qualité de vie, de
périmètre de marche, de pic de VO2, d’asynchronisme 3D et de fraction d’éjection.tudy protocol
ll patients underwent echocardiography, a quality-of-life
ssessment using the Minnesota living with heart failure
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Figure 1. After implantation of the cardiac resynchronization therapy device, ﬂuoroscopic orthogonal views (right anterior oblique [RAO]
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aat 30◦ and left anterior oblique [LAO] at 60◦) were acquired. LAO a
basal, medial and apical sections.
questionnaire, a 6-minute hall walk test and a maximal bicy-
cle and treadmill cardiopulmonary test with measurement
of peak exercise oxygen consumption within 5 days before
implantation and after 6months of simultaneous biventric-
ular pacing.
Biventricular device implantation and programming
All leads were implanted transvenously. The atrial lead was
positioned conventionally at the right atrial appendage and
the right ventricular lead at the apex of the right ventricle.
The LV lead was positioned through the coronary sinus into a
posterior (n = 9), lateral (n = 23) or anterior (n = 12) cardiac
vein. The physician who implanted the LV lead was blinded to
the results of the echocardiographic examination. In clinical
practice, a lateral or a posterior vein is usually targeted. In
this study, the priority was to achieve a stable position with
suitable threshold and absence of diaphragmatic pacing.
No intraoperative haemodynamic evaluation was carried
out. The pacing leads were connected to a biventricular
implantable cardioverter-deﬁbrillator (InSync Sentry 7298,
Medtronic [Minnesota, USA] Contak Renewal 4 HE, Guidant
[Minneapolis, USA]). For 3 days, the patients were not paced
in the ventricles (AAI mode, 40 beats/minute). Three days
after implantation, the atrioventricular delay was optimized
echocardiographically during biventricular pacing to provide
the longest transmitral LV ﬁlling time without truncation of
the A-wave obtained from pulsed Doppler analysis of the
LV ﬁlling. The interventricular timing was set to 0 in all
patients.
Echocardiographic evaluations
Real-time 3D echocardiography was performed 3 days before
implantation, 3 days after implantation and after 6months
of simultaneous biventricular pacing, using a 3D probe
connected to a 3D digital ultrasound system (Vivid 7,
GE Vingmed, Horton, Norway). During the echocardiogra-
phy 3 days after implantation, echocardiographic recordings
were made during atrio-sensed right ventricular pacing and
A
i
T
u
i: the resized 16-segment scheme was projected. RAO: divided into
trio-sensed simultaneous biventricular pacing. All echocar-
iographic recordings were made by the same physician
o minimize variability between examinations. All images
ere recorded digitally and analysed off-line. The off-
ine analysis was performed by an observer blinded to
he ﬂuoroscopic lead positions (Fig. 1). A full-volume loop
f the left ventricle was acquired using an apical posi-
ion of the probe during a short breath hold. The LVEF,
VESV and LVEDV were determined off-line with the aid
f semiautomatic contour tracing software (4D LV-Analysis,
omTec, Unterschleissheim, Germany) as described previ-
usly [14]. A 3D parameter of dyssynchrony was obtained
rom the time-course of shortening in 16 LV segments and
he resulting segmental volume/time curves. The 3D dyssyn-
hrony index was deﬁned as the standard deviation of the
6 segmental shortening durations to reach minimum seg-
ental volume [15]. To allow comparisons between patients
ith signiﬁcantly different heart rates, this variable was
xpressed as a percentage of the cardiac cycle dura-
ion.
Based on the resulting segmental volume/time curve
n each patient, the segment with the latest minimum of
ystolic volume as an indicator for latest systolic contrac-
ion was identiﬁed before implantation and deﬁned as the
egment with maximum mechanical delay. Similarly, 3 days
fter implantation, the segment with the latest minimum of
ystolic volume as an indicator for latest systolic contraction
as identiﬁed during right ventricular pacing.
oncordance between most delayed
chocardiographic left ventricular segment
spontaneous rhythm and right ventricular pacing)
nd left ventricular pacing site
fter CRT implantation, biplane ﬂuoroscopy was performed
n left anterior and right anterior oblique orthogonal views.
hese images were analysed by two independent physicians
sing a 16-segment scheme, identical to the scheme used
n the 4D LV-analysis (TomTec, Unterschleissheim, Germany)
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nd projected onto the left anterior oblique view to deter-
ine the anatomical location of the LV lead within the
ircumference of that level. The right anterior oblique view
as used subsequently to deﬁne the basal, medial or apical
evel of the LV lead.
A correlation between the ﬂuoroscopic LV pacing site and
he most delayed echocardiographically-determined LV site
as assessed blindly, as described previously [11], by two
bservers with full concordance. The physicians performing
chocardiographic analysis and classiﬁcation of LV lead posi-
ion as optimal or non-optimal were blinded with regard to
ossible difﬁculties during LV lead placement and anatomi-
al limitations.
tatistical analysis
nterobserver and intraobserver reproducibility of 3D
chocardiographic measurements were assessed with lin-
ar regression analysis and the Bland-Altman method in
2 patients (mean age 53± 16 years; 28men) who were
ot included in the present study. These patients were
elected to demonstrate different levels of LV dysfunc-
ion ranging from normal heart to severe cardiomyopathy.
ontinuous variables are presented as means± standard
eviations. Categorical data are presented as frequencies
nd percentages. Sequential data measurements were anal-
sed by repeated measures analysis of variance followed
y Scheffé’s procedure for multiple comparisons. Statistical
igniﬁcance was established at p < 0.05.
esultshe patients’ baseline characteristics are presented in
able 1. The entire study protocol was completed in all
4 patients. No patient died during the 6-month follow-up
eriod. Interobserver variability mean average error and 95%
onﬁdence interval values obtained from the Bland and Alt-
Table 1 Demographic and clinical characteristics at
baseline; total population (n = 44).
Characteristic
Age (years) 67.5± 8
Men 38 (86)
Ischaemic dilated cardiomyopathy 26 (59)
Non-ischaemic dilated cardiomyopathy 18 (41)
New York Heart Association class 3.2± 0.3
Ejection fraction (%) 25.8± 7
QRS width (ms) 160± 27
Concomitant therapy
ACE inhibitor 30 (68)
AT1 receptor antagonist 10 (22)
Beta-blocker 40 (91)
Diuretic 44 (100)
Aldosterone antagonist 33 (75)
Values are mean± standard deviation or number (%).
ACE: angiotensin-converting enzyme; AT1: angiotensin type 1.
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an analysis of 3D LVEF, 3D LVESV and 3D LVEDV were −0.2
nd 3.3%, −1.2 and 13.7mL, and −0.2 and 16.1mL, respec-
ively. Intraobserver variability mean average error and 95%
onﬁdence interval values obtained from the Bland and Alt-
an analysis of 3D LVEF, 3D LVESV and 3D LVEDV were 0.1
nd 2.8%, −0.1 and 8.4mL, and 0.3 and 9.6mL, respectively
Figs. 2 and 3).
In 19 patients (Group 1), the LV lead position determined
y ﬂuoroscopy was found to be concordant with the site
f the most delayed mechanical activation determined in
pontaneous rhythm before implantation. The LV lead was
ositioned in the following segments: nine lateral (three
asal, ﬁve medial and one apical), six anterior (two basal
nd four medial) and four posterior (one basal and three
edial). In 25 patients (Group 2), the LV lead position did
ot match with the most delayed site. The LV lead was
ositioned in the following segments: 14 lateral (four basal,
ine medial and one apical), six anterior (four basal and
wo medial) and ﬁve posterior (four medial and one api-
al).
In 21 patients (Group 3), the LV lead position determined
y ﬂuoroscopy was found to be concordant with the site of
he most delayed mechanical activation determined during
ight ventricular pacing after implantation. The LV lead was
ositioned in the following segments: 11 lateral (ﬁve basal,
ve medial and one apical), four anterior (three basal and
ne medial) and six posterior (one basal and ﬁve medial). In
3 patients (Group 4), the LV lead position did not match
ith the most delayed site during right ventricular pac-
ng. The LV lead was positioned in the following segments:
2 lateral (two basal, nine medial and one apical), eight
nterior (three basal and ﬁve medial) and three posterior
two medial and one apical).
There was no difference between patients in Groups 1
nd 2 or between patients in Groups 3 and 4 in terms of
emographic, clinical and echocardiographic characteristics
t baseline, or in the distribution of the location of the most
elayed segment (Tables 2 and 3).
Three days after implantation, a signiﬁcant increase
as observed compared with baseline in real-time
D echocardiographically-determined LVEF (31.8± 7% vs
5.8± 7%, r < 0.05) and a decrease in the dyssynchrony index
6.7± 1.8% vs 9.9± 2.9%; p < 0.05) in the overall population,
ithout signiﬁcant difference between the four groups.
After 6months of simultaneous biventricular pacing,
signiﬁcant improvement was observed in clinical sta-
us in terms of New York Heart Association functional
lass (2.3± 0.3 vs 3.2± 0.3, p < 0.05), Minnesota living with
eart failure questionnaire (30± 15 vs 54± 18, p < 0.05),
-minute walk test (415± 83m vs 296± 69m, p < 0.05)
nd peak oxygen consumption (15.2± 3.8mL/kg/min vs
3.4± 3.5mL/kg/min, p < 0.05) in the overall popula-
ion, compared with baseline. These beneﬁcial effects of
RT were supported by a decrease in LVESV (99± 48mL
s 130± 69mL, p < 0.05) and LVEDV (144± 60mL vs
76± 80mL, p < 0.05), an increase in LVEF (33.3± 6.4% vs
7.5± 7%, p < 0.05) and a decrease in the dyssynchrony index
4.9± 1.2% vs 9.9± 2.9%, p < 0.05).
After 6months of simultaneous biventricular pacing, no
igniﬁcant differences were observed in any of the stud-
ed variables between patients in Group 1 and Group 2 or
etween patients in Group 3 and Group 4.
Absence of additional improvement in outcome of patients receiving cardiac resynchronization 645
Figure 2. Interobserver reproducibility in terms of three-dimensional left ventricular ejection fraction (LVEF), left ventricular end-diastolic
volume (LVEDV) and left ventricular end-systolic volume (LVESV).
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F
v
igure 3. Intraobserver reproducibility in terms of three-dimensional le
olume (LVEDV) and left ventricular end-systolic volume (LVESV).ft ventricular ejection fraction (LVEF), left ventricular end-diastolic
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Table 2 Demographic, clinical and echocardiographic characteristics at baseline in patients with left ventricular lead
position concordant or non-concordant with most delayed site.
Characteristic Group 1(n = 19) Group 2(n = 25) Group 1
vs 2
p
Group 3(n = 21) Group 4(n = 23) Group 3
vs 4
p
Age (years) 66.4± 6.5 68.5± 7.4 0.24 65.1± 6.3 69.9± 7.8 0.31
Men 16 (84) 22 (88) 0.72 17 (81) 21 (91) 0.32
Ischaemic heart disease 11 (58) 15 (60) 0.89 12 (57) 17 (74) 0.24
QRS duration (ms) 165± 21 157± 23 0.58 169± 20 153± 25 0.45
New York Heart
Association
functional class
3.2± 0.6 3.2± 0.6 0.88 3.1± 0.6 3.2± 0.6 0.81
QOL score 50± 17 57± 19 0.34 52± 14 56± 20 0.36
6-minute walking test
(m)
302± 65 289± 72 0.43 292± 65 297± 72 0.48
Peak oxygen
consumption
(mL/kg/min)
13.6± 3.2 13.1± 3.6 0.54 12.9± 3.1 13.7± 3.6 0.39
LVESV (mL) 123± 56 133± 75 0.41 132± 69 126± 71 0.52
LVEDV (mL) 165± 65 180± 86 0.37 180± 84 166± 78 0.33
LVEF (%) 25.5± 7 26.1± 7 0.61 27± 7 24.7± 7 0.28
3D dyssynchrony index
(%)
10± 2.8 9.8± 2.9 0.65 10.7± 2.8 9.2± 2.8 0.26
Values are mean± standard deviation or number (%).
lQOL: quality of life.
DiscussionImpact of the left ventricular pacing site
In patients requiring CRT, the choice of optimal LV pacing
site remains an issue. Systematic implantation of the LV
t
H
i
d
a
Table 3 Percentage change between baseline and 6-month fol
or non-concordant with most delayed site.
Group 1
(n = 19)
Group 2
(n = 25)
Grou
p
 New York Heart
Association
functional class (%)
−31 ± 11 −28 ± 13 0.27
 Minnesota QOL score
(%)
−46 ± 26 −44 ± 21 0.45
 6-minute walking
test (%)
+42 ± 18 +38 ± 18 0.39
 Peak oxygen
consumption VO2
max (%)
+14 ± 5 +13 ± 6 0.17
 LVESV (%) −21 ± 8 −24 ± 13 0.32
 LVEDV (%) −15 ± 8 −18 ± 11 0.34
 LVEF (%) +21 ± 14 +27 ± 15 0.18
 3D dyssynchrony
index (%)
−47 ± 22 −44 ± 24 0.34
Values are mean± standard deviation.
QOL: quality of life.ead at the lateral wall is often recommended, simplifying
he choice when a suitable lateral vein can be cannulated.
owever, the existence of an identical, unique, optimal pac-
ng site, i.e., the lateral wall, for all implanted patients,
espite major interpatient differences in electromechanical
ctivation, seems very unlikely. Tailoring of the LV lead posi-
low-up results in patients with LV lead position concordant
p 1 vs 2 Group 3
(n = 21)
Group 4
(n = 23)
Group 3 vs 4
p
−29 ± 10 −30 ± 14 0.35
−41 ± 22 −48 ± 25 0.28
+39 ± 16 +42 ± 21 0.35
+16 ± 6 +12 ± 4 0.27
−24 ± 8 −23 ± 13 0.42
−18 ± 9 −16 ± 11 0.38
+20 ± 12 +28 ± 17 0.14
−51 ± 19 −42 ± 26 0.17
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ion may provide additional haemodynamic improvement
nd optimization of the pacing site for each patient may be
ecommended. Therefore, any technique or strategy that
ight optimize LV lead position deserves interest.
chocardiography to select the optimal pacing
ite
n an experimental study that included a very limited num-
er of patients, tailoring of the LV lead position to the
rea of maximal electrical delay resulted in the best acute
esynchronization effect [16]. The human results in terms of
linical impact, reverse remodelling and reduction of mor-
ality associated with this strategy are still controversial
17,18].
In our present study, echocardiographic optimization
f the LV lead position based on a detailed analysis of
he myocardial contraction sequence before implantation
as not associated with additional short-term or long-term
mprovement. Our results contradict some results published
reviously, despite having a similar study design [11]. This
iscordance highlights the disparity in results obtained with
chocardiography in the context of CRT. Our study (and oth-
rs) combined complex techniques, such as tissue Doppler
maging, tissue synchronization imaging or real-time 3D
chocardiography, to deﬁne the segment with most delayed
ctivation. In a recent, prospective, multicentre trial, the
bility of several conventional two-dimensional echocar-
iographic variables and techniques to predict response to
RT was evaluated [19]. Poor interobserver reproducibil-
ty with the use of these variables and techniques may
xplain why studies with similar design produce conﬂicting
esults. However, the absence of an additional beneﬁcial
ffect with LV implantation in the most delayed region in
ur study might have a more pathophysiological explana-
ion. In a high proportion of patients, biventricular pacing
s performed with complete capture and absence of fusion
etween intrinsic and ectopic rhythms. Therefore, the elec-
romechanical activation after CRT depends on the location
f the pacing leads and on the electromechanical proper-
ies of the LV myocardium, independent of the LV activation
attern before implantation. As ventricular pacing induces
reas of early activation around the pacing lead and areas
f late activation at a distance from the lead, it is likely
hat stimulation in the most delayed region, determined in
pontaneous rhythm, will convert this zone into an early
ctivated site, whereas previous regions of early activation
ill be delayed. We believe that there is no reason for these
odiﬁcations in electromechanical activation to be associ-
ted with a maximal reduction in ventricular dyssynchrony
r with optimal acute haemodynamic or long-term clini-
al improvements. Furthermore, in patients with ischaemic
ardiomyopathy, the most delayed segments are often com-
osed of viable but ischaemic tissue, while pacing the
schaemic area has been demonstrated to be ineffective, if
ot deleterious [20]. Preprocedural echocardiography may
ot therefore be the adequate tool for predicting the opti-
al pacing sites.
In contrast, periprocedural echocardiographic compar-
sons between the different pacing sites may be technically
ifﬁcult but more appropriate for determining the LV pac-A. Deplagne et al.
ng site, associated with maximal reduction in ventricular
yssynchrony and maximal haemodynamic improvement.
chocardiography may be performed during the procedure
o determine the optimal LV pacing site based on a detailed
nalysis of the myocardial contraction sequence once the
orrect ventricular lead has been implanted. Our present
tudy assessed the putative favourable impact of targeting
he most delayed LV region during right ventricular pacing.
nfortunately, we did not demonstrate an increased bene-
t with an echocardiographically-optimized LV lead position
argeting the exact region of maximal mechanical delay
uring right ventricular pacing. Therefore, just like prepro-
edural echocardiography, this strategy may not be helpful
n improving the response to the therapy.
imitations
he study population size was rather small and the sta-
istical analysis may have been underpowered. Moreover,
he duration of follow-up was rather short. Therefore, this
tudy should probably be considered as a pilot study. A
ulticentre, randomized study is warranted to conﬁrm the
linical impact of pre-implantation echocardiographically
uided selection of the LV pacing site.
onclusions
his prospective study compared the outcome of patients
aced at the most delayed LV region with that of patients
aced at any other LV site. Implantation of the LV lead in the
ost delayed region of the left ventricle determined by 3D
chocardiography did not result in additional improvement
n symptoms or LV function.
onﬂict of interest
one.
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